Bellus Health Raises $70M In Upsized Stateside IPO
Quebec-based biopharmaceutical company Bellus Health Inc. on Thursday said it raised $70 million in an upsized U.S. initial public offering led by Davies Ward Phillips & Vineberg LLP and Troutman Sanders...To view the full article, register now.
Already a subscriber? Click here to view full article